Search

Search Results

##search.searchResults.foundPlural##

BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN

Maria Teresa Voso, Giulia Falconi, Dr. Fabiani

e2023055

2023-08-29

https://doi.org/10.4084/MJHID.2023.055

1820

PDF: 991

HTML: 147
Impressive continuous complete response after mogamulizumab in a heavily pre-treated Sézary syndrome patient

Pier Luigi Zinzani, Ginevra Lolli, Beatrice Casadei, Lisa Argnani, Laura Nanni, Michele Cavo

e2020040

2020-06-28

https://doi.org/10.4084/mjhid.2020.040

1080

PDF: 693

HTML: 202
Achieving the cure of follicular lymphoma: is it time to finalize treatment strategies to reach this goal in a subset of patients?

Mauro Passucci, Giovanni Assanto, Alessandro Pulsoni

e2023018

2023-02-28

https://doi.org/10.4084/MJHID.2023.018

1240

PDF: 920

HTML: 365
OUTCOME AND TOXICITY PATTERNS IN CHILDREN AND ADOLESCENTS WITH NON-HODGKIN LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE

Paola Angelini, Laura Rodriguez, Mohammed Zolaly, Ahmed Naqvi, Sheila Weitzman, oussama Abla, Angela Punnett

e2018020

2018-03-01

https://doi.org/10.4084/mjhid.2018.020

2889

PDF: 836

HTML: 377
SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs

Massimo Breccia, Giuliana Alimena

e2014003

2014-01-02

https://doi.org/10.4084/mjhid.2014.003

3287

PDF: 1227

HTML: 3475
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association

Katia Paciaroni, Selenia Campagna, Nicoletta Villiva', Enrico Maffini, Francesca Celesti, Attilio Tordi, Mariangela Lombardi, Giulia Dragonetti, Tommaso Caravita di Toritto

e2025023

2025-02-27

https://doi.org/10.4084/MJHID.2025.023

1085

PDF: 1168

HTML: 98
TREATMENT OUTCOMES AND CLINICAL RELEVANCE IN PATIENTS WITH DOUBLE EXPRESSOR DLBCL Sirapat Rungwittayatiwat1, Paisarn Boonsakan2, Pichika Chantrathammachart1, Teeraya Puavilai1, Sulada Pukiat1, Sithakom Phusanti1,3, Kochawan Boonyawat1, Pathawut Wacharapornin1, Pantep Angchaisuksiri1, Artit Ungkanont1,3, Suporn Chuncharunee1 Pimjai Niparuck1

PIMJAI NIPARUCK

e2021063

2021-10-29

https://doi.org/10.4084/MJHID.2021.063

1187

PDF: 541

HTML: 212
HEALTH-RELATED QUALITY OF LIFE MEASUREMENT IN ADULTS WITH SICKLE CELL DISEASE IN STEADY STATE: EXPERIENCE OF ONE FRENCH REFERENCE CENTER

Giovanna Cannas, Solene Poutrel, Emilie Virot, Manon Marie, Alexandre Guilhem, Amal El-Kanouni, Richard Bourgeay, Marie-Grace Mutumwa, Mohamed Elhamri, Arnaud Hot

e2025065

2025-08-31

https://doi.org/10.4084/MJHID.2025.065

998

PDF: 533

Html: 149
Ixazomib-associated skin exfoliation

Yali Zhang, Long Zhao, Yuancheng Guo, bei liu

e2022045

2022-04-28

https://doi.org/10.4084/MJHID.2022.045

868

PDF: 552

HTML: 213
Simultaneous presentation of Hemophagocytic Lymphohistiocytosis and Classical Hodgkin's Lymphoma in a patient with underlying germline homozygous STXBP2 Mutation.

Dr Shilpa Gupta, Dr Amrita Rajendran , Dr Akanksha Chichra , Dr Ayubali Qureshi

e2026043

2026-04-30

https://doi.org/10.4084/MJHID.2026.043

258

PDF: 185

HTML: 17
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis

Roberta Zanotti, Massimiliano Bonifacio, Ilaria Tanasi, Donatella Schena, Giovanni Orsolini, Morena Tebaldi, Lara Crosera, Francesca Mastropaolo, Elisa Olivieri, Dr. Patrizia Bonadonna

e2021068

2021-10-29

https://doi.org/10.4084/MJHID.2021.068

1576

PDF: 1042

HTML: 238
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia

Buket Altinok Gunes, Yalda Hekmatshoar, Tulin Ozkan, Sureyya Bozkurt, O.Sena Aydos, Yahya Buyukasik, Elifcan Aladag, Asuman Sunguroglu

e2023008

2023-01-01

https://doi.org/10.4084/MJHID.2023.008

1349

PDF: 1240

HTML: 461
EBV AND HIV-RELATED LYMPHOMA

Michele Bibas, Andrea Antinori

e2009032

2009-12-29

https://doi.org/10.4084/mjhid.2009.032

1587

PDF: 643

HTML: 6877
PREVALENCE OF THALASSEMIA IN THE VIETNAMESE POPULATION AND BUILDING A CLINICAL DECISION SUPPORT SYSTEM FOR PRENATAL SCREENING FOR THALASSEMIA

Danh Cuong Tran, Anh Linh Dang, Thi Ngoc Lan Hoang, Chi Thanh Nguyen, Thi Ngoc Mai Dinh, Van Anh Tran, Thi Kim Phuong Doan, Thi Trang Nguyen

e2023026

2023-04-28

https://doi.org/10.4084/MJHID.2023.026

4759

HTML: 324

PDF: 1259
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1

kang sun

e2024037

2024-04-30

https://doi.org/10.4084/MJHID.2024.037

2804

PDF: 1097

HTML: 121
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”

Sara Martinelli, Antonio Cuneo, Gian Matteo Rigolin

e2016047

2016-10-15

https://doi.org/10.4084/mjhid.2016.047

4018

PDF: 1057

HTML: 3603

Untitled: 178

Cneo. Fig.1: 115

Untitled: 108

Untitled: 129

Untitled: 135
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones

Antonio Cristiano, Raffaele Palmieri, Emiliano Fabiani, Tiziana Ottone, Mariadomenica Divona, Arianna Savi, Francesco Buccisano, Luca Maurillo, Corrado Tarella, William Arcese, Maria Teresa Voso

e2022041

2022-04-28

https://doi.org/10.4084/MJHID.2022.041

1276

PDF: 772

HTML: 320
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA

Davide Rossi, Marco Fangazio, Gianluca Gaidano

e2012076

2012-11-13

https://doi.org/10.4084/mjhid.2012.076

2282

PDF: 896

HTML: 2006

Fig 1 Rossi: 185
CORD BLOOD PLATELET LYSATE: IN VITRO EVALUATION TO SUPPORT THE USE IN REGENERATIVE MEDICINE. Cord and adult blood platelet lysates

Luciana Teofili

e2019021

2019-02-25

https://doi.org/10.4084/mjhid.2019.021

2065

PDF: 1150

HTML: 253
Seven-Year Course of Hypoplastic Myelodysplastic Syndrome Unmasked by Secondary and Neurosyphilis.

Ali Turunç, Hüseyin Derya Dinçyürek, Birol Güvenç

e2026026

2026-02-28

https://doi.org/10.4084/MJHID.2026.026

493

PDF: 353

HTML: 170
ANTIFUNGAL SUSCEPTIBILITY TESTING: CURRENT ROLE FROM THE CLINICAL LABORATORY PERSPECTIVE

Brunella Posteraro, Riccardo Torelli, Elena De Carolis, Patrizia Posteraro, Maurizio Sanguinetti

e2014030

2014-04-07

https://doi.org/10.4084/mjhid.2014.030

1993

PDF: 1293

HTML: 6430
A case of central venous catheter-related Candida parapsilosis fungemia evolved to disseminated infection in a neutropenic patient with blast crisis of chronic myeloid leukemia.

Elena Amabile, Matteo Totaro, Luca Cappelli, Clara Minotti, Alessandra Micozzi

e2024013

2024-01-01

https://doi.org/10.4084/MJHID.2024.013

940

PDF: 1176

HTML: 164
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS

Eleonora De Bellis, Luana Fianchi, Francesco Buccisano, Marianna Criscuolo, Luca Maurillo, Laura Cicconi, Mattia Brescini, Maria Ilaria Del Principe, Ambra Di Veroli, Adriano Venditti, Francesco Lo-Coco, Maria Teresa Voso

e2017045

2017-07-01

https://doi.org/10.4084/mjhid.2017.045

4386

PDF: 1772

HTML: 1111
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines

Alex Shimanovsky, Devbala Patel, Jeffrey Wasser

e2016010

2016-01-01

https://doi.org/10.4084/mjhid.2016.010

4277

PDF: 1196

HTML: 2171

Figure 1: 170
THE CHALLENGE OF AML IN OLDER PATIENTS

Alan K Burnett

e2013038

2013-06-03

https://doi.org/10.4084/mjhid.2013.038

2199

PDF: 977

HTML: 2172

251 - 275 of 275 items << < 1 2 3 4 5 6

Search

Search Results

BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN

Impressive continuous complete response after mogamulizumab in a heavily pre-treated Sézary syndrome patient

Achieving the cure of follicular lymphoma: is it time to finalize treatment strategies to reach this goal in a subset of patients?

OUTCOME AND TOXICITY PATTERNS IN CHILDREN AND ADOLESCENTS WITH NON-HODGKIN LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE

SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs

THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association

HEALTH-RELATED QUALITY OF LIFE MEASUREMENT IN ADULTS WITH SICKLE CELL DISEASE IN STEADY STATE: EXPERIENCE OF ONE FRENCH REFERENCE CENTER

Ixazomib-associated skin exfoliation

Simultaneous presentation of Hemophagocytic Lymphohistiocytosis and Classical Hodgkin's Lymphoma in a patient with underlying germline homozygous STXBP2 Mutation.

SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis

DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia

EBV AND HIV-RELATED LYMPHOMA

PREVALENCE OF THALASSEMIA IN THE VIETNAMESE POPULATION AND BUILDING A CLINICAL DECISION SUPPORT SYSTEM FOR PRENATAL SCREENING FOR THALASSEMIA

LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1

“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”

The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones

THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA

CORD BLOOD PLATELET LYSATE: IN VITRO EVALUATION TO SUPPORT THE USE IN REGENERATIVE MEDICINE. Cord and adult blood platelet lysates

Seven-Year Course of Hypoplastic Myelodysplastic Syndrome Unmasked by Secondary and Neurosyphilis.

ANTIFUNGAL SUSCEPTIBILITY TESTING: CURRENT ROLE FROM THE CLINICAL LABORATORY PERSPECTIVE

A case of central venous catheter-related Candida parapsilosis fungemia evolved to disseminated infection in a neutropenic patient with blast crisis of chronic myeloid leukemia.

TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS

Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines

THE CHALLENGE OF AML IN OLDER PATIENTS

Links

Information

Indexing

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

AskBisht

Facebook

MJHID in EuroPub Database

CLL UpDate

Keywords